New drug nascertib tested in healthy volunteers – no cure expected
NCT ID NCT07600762
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This early-stage study tests a single dose of nascertib in 12 healthy Japanese adults to see how safe it is and how the body processes it. Participants are monitored for side effects and drug levels in the blood. The goal is to gather basic safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel ACT- Anaheim Clinical Trials /ID# 282482
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.